MetaCap

TransMedics Group Statistics

NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

81.07+0.79 (+0.98%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

TransMedics Group by the numbers

TransMedics Group has a market capitalization of $2.81 billion based on 34.68M shares outstanding. Its trailing P/E ratio is 21.0, below the 5-company peer median of 22.5, and its forward P/E is 36.0. The stock trades 5.4% below its 50-day average and 18.4% below its 200-day average.

Average daily trading volume is 815.54K shares, or about $66.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TMDX valuation vs. peer median

TMDX compared with the median of 8 peer companies
MetricTMDXPeer medianDifference
Market cap$2.81B$1.11B+153%
P/E (TTM)21.022.5-7%
Forward P/E36.017.3+108%
Avg. volume815.54K507.82K+61%

Peer median across 8 companies: AXGN, LIVN, CNMD, ITGR, CBLL, INMD, CV, ELMD.

Valuation

Price / sales (latest FY)
4.64

Price and trading

Previous close
80.28
Open
80.96
Day range
80.56 – 83.90
52-week range
60.11 – 156.00
52-week change
-29.61%
Beta
—
Volume
962.41K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.81B
Pe
21.00
Forward Pe
35.96
Eps
3.86
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
156.00
Week52 Low
60.11
Avg Volume
815.54K
Shares Outstanding
34.68M
Ma50
85.68
Ma200
99.37
Earnings Date
Nov 4, 2026
Pct From52w High
-48.03%
Pct From52w Low
34.88%

Related